NCT00279968

Brief Summary

The purpose of the Registry is to collect data on how Implantable Cardioverter Defibrillator (ICD) therapies and medications are being used by physicians to treat ventricular arrhythmias in order to better understand how to improve the clinical care of patients and effectiveness of ICD therapies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,326

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2004

Geographic Reach
1 country

44 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2004

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2006

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

January 19, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 20, 2006

Completed
Last Updated

December 28, 2007

Status Verified

December 1, 2007

First QC Date

January 19, 2006

Last Update Submit

December 26, 2007

Conditions

Ventricular TachycardiaVentricular Fibrillation

Keywords

ICDRegistryVentricular tachycardiaVentricular Fibrillation

Interventions

ICDDEVICE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients 18 years of age or older.
  • Patients or legal guardians who are willing and able to sign a Permission for Access to and Use of Health Information in a Registry Form and, if required by an Institution's IRB, an Informed Consent.
  • New or replacement implants of Medtronic market released single, dual or triple chamber ICDs including: GEM VR, GEM DR, GEM III AT, Marquis VR, Marquis DR, Maximo DR, Maximo VR, InSync ICD, InSync Marquis ICD and InSync II Marquis ICD.

You may not qualify if:

  • Patients enrolled in a device study which effects programming and or treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (44)

Unknown Facility

Little Rock, Arkansas, United States

Location

Unknown Facility

Fountain Valley, California, United States

Location

Unknown Facility

Poway, California, United States

Location

Unknown Facility

Sacramento, California, United States

Location

Unknown Facility

Santa Ana, California, United States

Location

Unknown Facility

Boulder, Colorado, United States

Location

Unknown Facility

Bradenton, Florida, United States

Location

Unknown Facility

Lakeland, Florida, United States

Location

Unknown Facility

Lauderdale Lakes, Florida, United States

Location

Unknown Facility

Palm Beach Gardens, Florida, United States

Location

Unknown Facility

Panama City, Florida, United States

Location

Unknown Facility

Pembroke Pines, Florida, United States

Location

Unknown Facility

Tampa, Florida, United States

Location

Unknown Facility

Atlanta, Georgia, United States

Location

Unknown Facility

Gainesville, Georgia, United States

Location

Unknown Facility

Chicago, Illinois, United States

Location

Unknown Facility

Crown Point, Indiana, United States

Location

Unknown Facility

Noblesville, Indiana, United States

Location

Unknown Facility

Monroe, Louisiana, United States

Location

Unknown Facility

Annapolis, Maryland, United States

Location

Unknown Facility

Glen Burnie, Maryland, United States

Location

Unknown Facility

Boston, Massachusetts, United States

Location

Unknown Facility

Detroit, Michigan, United States

Location

Unknown Facility

Kalamazoo, Michigan, United States

Location

Unknown Facility

Columbia, Missouri, United States

Location

Unknown Facility

Omaha, Nebraska, United States

Location

Unknown Facility

Newark, New Jersey, United States

Location

Unknown Facility

Pomona, New Jersey, United States

Location

Unknown Facility

Brooklyn, New York, United States

Location

Unknown Facility

Mineola, New York, United States

Location

Unknown Facility

Williamsville, New York, United States

Location

Unknown Facility

Charlotte, North Carolina, United States

Location

Unknown Facility

Minot, North Dakota, United States

Location

Unknown Facility

Cincinnati, Ohio, United States

Location

Unknown Facility

Cleveland, Ohio, United States

Location

Unknown Facility

Kettering, Ohio, United States

Location

Unknown Facility

Lancaster, Pennsylvania, United States

Location

Unknown Facility

Langhorne, Pennsylvania, United States

Location

Unknown Facility

Providence, Rhode Island, United States

Location

Unknown Facility

Austin, Texas, United States

Location

Unknown Facility

Fort Worth, Texas, United States

Location

Unknown Facility

Houston, Texas, United States

Location

Unknown Facility

McAllen, Texas, United States

Location

Unknown Facility

Fredericksburg, Virginia, United States

Location

MeSH Terms

Conditions

Tachycardia, VentricularVentricular Fibrillation

Condition Hierarchy (Ancestors)

TachycardiaArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Alfred Buxton, MD

    Rhode Island Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

January 19, 2006

First Posted

January 20, 2006

Study Start

February 1, 2004

Study Completion

January 1, 2006

Last Updated

December 28, 2007

Record last verified: 2007-12

Locations

US(44)